Harpreet S. Dhaliwal - 30 Dec 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP Cml Mfg & Supply Chain
Signature
Harpreet S. Dhaliwal, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
30 Dec 2022
Transactions value $
$0
Form type
4
Filing time
04 Jan 2023, 15:32:51 UTC
Previous filing
30 Dec 2022
Next filing
25 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Award $0 +15K $0.00 15K 30 Dec 2022 Common Stock 15K $47.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Harpreet S. Dhaliwal is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.